Advertisement
Advertisement

SPRY

SPRY logo

ARS Pharmaceuticals, Inc. Common Stock

17.68
USD
-0.24
-1.35%
Jul 31, 16:00 UTC -4
Closed
exchange

Pre-Market

17.49

-0.19
-1.07%

ARS Pharmaceuticals, Inc. Common Stock Profile

Info & Links

CEO

Richard Lowenthal

Headquarters

11682 El Camino Real, Suite 120
San Diego, CA 92130, UNITED STATES

Sector

Medical

Auditor

Ernst & Young LLP

Share holders

16

Employees

160

ARS Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.72B

Enterprise Value

1.75B

Enterprise Value/EBITDA(ttm)

-51.46

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

94.97%

Operating Margin(ttm)

--

Profit Margin(ttm)

-949.04%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-11.40%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

97.12M

Revenue Per Share(ttm)

0.99

Gross Profit(ttm)

95.05M

EBITDA(ttm)3

-33.95M

Net Income Available to Common(ttm)

-15.65M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

62.65%

S&P 500 52-Week Change

16.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

98.21M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

275.73M

Total Cash Per Share(mrq)

2.81

Total Debt(mrq)

69.38M

Total Debt/Equity(mrq)

30.30%

Current Ratio(mrq)

11.00%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

2.33

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.42

Free Cash Flow(ytd)

-40.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement